Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial (Aug, 10.1200/JCO.20.00799, 2020)-MedSci.cn

Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial (Aug, 10.1200/JCO.20.00799, 2020)

DiSilvestro

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (12): 1414

科室
- - 订阅+
  - 更多科室
工具
服务